Skip to main content
Fuji Pharma Co.,Ltd. logo

Fuji Pharma Co.,Ltd. — Investor Relations & Filings

Ticker · 4554 ISIN · JP3816200004 LEI · 529900L1XVCEHVKHAM60 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country JP Japan
Listing T 4554

About Fuji Pharma Co.,Ltd.

https://www.fujipharma.jp/english/ir/

Fuji Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription medical products. The company's primary focus is on women's healthcare, including hormonal preparations for obstetrics and gynecology, alongside curative medicines and in-vitro diagnostics. Its portfolio includes both specialty and generic drugs. In addition to developing its own pharmaceuticals, Fuji Pharma offers extensive contract manufacturing services for a wide variety of dosage forms, such as solids, injections, ointments, creams, and liquids, for domestic and international clients.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 91% confidence The document is a formal confirmation (確���書) by the company’s president under Japan’s Financial Instruments and Exchange Act that the half-year report is properly stated. It contains no actual financial statements or data, only an officer certification. Per the certification rule, this type of attestation should be classified as a general regulatory filing, not as the interim report itself.
2026-05-13 Japanese
半期報告書－第62期(2025/10/01－2026/09/30)
Interim / Quarterly Report Classification · 95% confidence The document is labeled “半期報告書” (half-year report) filed under the Financial Instruments and Exchange Act, covering the interim period from October 1, 2025 to March 31, 2026. It contains full interim consolidated financial statements (balance sheet, income statement, cash flow statement), management’s discussion and analysis, risk factors, and other disclosures for the mid‐year period. This conforms exactly to an Interim/Quarterly Report rather than a mere announcement or summary. H1 2026
2026-05-13 Japanese
2026年９月期第２四半期有価証券評価損に関するお知らせ
Regulatory Filings Classification · 75% confidence The document is a brief Japanese-language press release titled “2026年9月期第2四半期有価証券評価損に関するお知らせ,” describing an impairment loss on securities for the second quarter of FY 2026. It does not present full quarterly financial statements or comprehensive results, nor is it announcing a general AGM, dividend, share issuance or financing. Rather, it is a stand-alone regulatory announcement of an accounting event that does not fit a more specific category, so it defaults to Regulatory Filings (RNS).
2026-05-12 Japanese
2026年９月期第２四半期(中間期)決算短信〔日本基準〕(連結)
Interim / Quarterly Report Classification · 95% confidence The document is a Japanese “決算短信” for the 2026第2四半期 (interim half-year) reporting period, containing full consolidated financial statements (income statement, balance sheet, cash flow, notes) and detailed narrative commentary. This matches the definition of an Interim/Quarterly Report (Code: IR). It is not merely an earnings highlight announcement but the substantive interim report itself. H1 2026
2026-05-12 Japanese
有価証券報告書－第61期(2024/10/01－2025/09/30)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes a formal header, specifies the fiscal year (第61期, 2024-10-01 to 2025-09-30), and contains XBRL-like metadata tags typical of a comprehensive annual financial filing submitted to the Kanto Local Finance Bureau. FY 2025
2025-12-18 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2025-12-18 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.